Chromeno[3,4-b]xanthones as First-in-Class AChE and Aβ Aggregation Dual-Inhibitors

Alzheimer’s disease (AD) is a complex multifactorial disorder, mainly characterized by the progressive loss of memory and cognitive, motor, and functional capacity. The absence of effective therapies available for AD alongside the consecutive failures in the central nervous system (CNS) drug development has been motivating the search for new disease-modifying therapeutic strategies for this disease. To address this issue, the multitarget directed ligands (MTDLs) are emerging as a therapeutic alternative to target the multiple AD-related factors. Following this concept, herein we describe the design, synthesis, and biological evaluation of a family of chromeno[3,4-b]xanthones as well as their (E)-2-[2-(propargyloxy)styryl]chromone precursors, as first-in-class acetylcholinesterase (AChE) and β-amyloid (Aβ) aggregation dual-inhibitors. Compounds 4b and 10 emerged as well-balanced dual-target inhibitors, with IC₅₀ values of 3.9 and 2.9 μM for AChE and inhibitory percentages of 70 and 66% for Aβ aggregation, respectively. The molecular docking showed that most of the compounds bound to AChE through hydrogen bonds with residues of the catalytic triad and π-stacking interactions between the main scaffold and the aromatic residues present in the binding pocket. The interesting well-balanced activities of these compounds makes them interesting templates for the development of new multitarget compounds for AD.     

H-aggregation mode in triple-decker phthalocyaninato-europium semiconductors. Materials design for high-performance air-stable ambipolar organic thin film transistors

Two new tris(phthalocyaninato) europium complexes Eu₂(Pc)[Pc(OPh)₈]₂ (1) and Eu₂[Pc(OPh)₈]₃ (2) [Pc = unsubstituted phthalocyaninate; Pc(OPh)₈ = 2,3,9,10,16,17,23,24-octaphenoxyphthalocyaninate], were designed and synthesized. Introduction of different number of electron-withdrawing phenoxy substituents at the phthalocyanine periphery within the triple-decker complexes not only ensures their good solubility in conventional organic solvents, but more importantly successfully tunes their HOMO and LUMO levels into the range of air-stable ambipolar organic semiconductor required on the basis of electrochemical studies over both 1 and 2, meanwhile fine controlling of aggregation mode (H vs. J) in solution-based film for improving OTFT performance is also achieved. Measurements over the OTFT devices fabricated from these sandwich compounds by a solution-based quasi–Langmuir–Shäfer (QLS) method reveal their ambipolar semiconductor nature associated with suitable HOMO and LUMO energy levels. Due to the H-aggregation mode employed by the heteroleptic triple-decker molecules in the QLS film, excellent performances with the electron and hole mobility in air as high as 0.68 and 0.014 cm² V⁻¹ s⁻¹, respectively, have been revealed for the OTFT devices of heteroleptic triple-decker 1. This represents the best performance so far for solution-processable ambipolar single-component phthalocyanine-based OTFTs obtained under ambient conditions. In good contrast, homoleptic analogue 2 prefers to J-type aggregation and this results in relatively lower electron and hole mobility, around 0.041 and 0.0026 cm² V⁻¹ s⁻¹ in air, respectively, for the devices fabricated. In particular, the performance of the devices fabricated based on 1 was found to remain almost unchanged in terms of both the carrier mobilities and on/off ratio even after being stored under ambient for 4 months.